New treatment options are being studied and proposed but much work is required to understand how these technologies are best matched with specific patients and pain syndromes.
A recent article delves into the details of this topic. The article concludes with a statement that "the field will undoubtedly continue to grow and force reconsideration of current treatment paradigms.".
This implies that new research on new paradigms require new devices. Flexible, programmable, indication-agnostic devices can play a key role in accelerating medical research, given the fact that developing a new purpose-built device requires a dedicated development team and heavy investment in time, and money.
A programmable device can enable new research overnight.